These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 10234897)
21. Immunohistochemical analysis of prostate-specific antigen does not correlate to other prognostic factors in breast cancer. Heyl W; Wolff JM; Biesterfeld S; Schröder W; Zitzelsberger D; Jakse G; Rath W Anticancer Res; 1999; 19(4A):2563-5. PubMed ID: 10470195 [TBL] [Abstract][Full Text] [Related]
22. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome? Vural B; Ozkan S; Bodur H J Obstet Gynaecol Res; 2007 Apr; 33(2):166-73. PubMed ID: 17441890 [TBL] [Abstract][Full Text] [Related]
23. Nipple aspirate fluid collection, related factors and relationship between carcinoembryonic antigen in nipple aspirate fluid and breast diseases in women in Harbin, PRC. Zhao YS; Pang D; Wang F; Xue YW; Gao DN; Li H; Li K; Wang BY; Wang D; Li HY Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):732-8. PubMed ID: 19273481 [TBL] [Abstract][Full Text] [Related]
24. [Determination of prostate-specific antigen (PSA) in cytosol of breast tumors and human endometrium--new diagnostic approaches]. Seliger E; Kaltwasser P; Röpke F Zentralbl Gynakol; 1998; 120(4):172-5. PubMed ID: 9610520 [TBL] [Abstract][Full Text] [Related]
25. Prostate-specific antigen in the serum of women with benign breast disease. Radowicki S; Kunicki M; Bandurska-Stankiewicz E Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):212-6. PubMed ID: 17850950 [TBL] [Abstract][Full Text] [Related]
26. Prostate specific antigen (PSA) in breast and ovarian cancer. Kucera E; Kainz C; Tempfer C; Zeillinger R; Koelbl H; Sliutz G Anticancer Res; 1997; 17(6D):4735-7. PubMed ID: 9494598 [TBL] [Abstract][Full Text] [Related]
27. Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes. Xu J; Meyers DA; Sterling DA; Zheng SL; Catalona WJ; Cramer SD; Bleecker ER; Ohar J Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):664-9. PubMed ID: 12101115 [TBL] [Abstract][Full Text] [Related]
28. Prognostic value of serum markers for prostate cancer. Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759 [TBL] [Abstract][Full Text] [Related]
29. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range. Haese A; Dworschack RT; Partin AW J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298 [TBL] [Abstract][Full Text] [Related]
30. Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers. Watson AP; Egland KA S D Med; 2010 Jul; 63(7):247-53. PubMed ID: 20666024 [TBL] [Abstract][Full Text] [Related]
31. Immunocytochemical detection of prostate specific antigen expression in human primary and metastatic melanomas. Bodey B; Bodey B; Kaiser HE Anticancer Res; 1997; 17(3C):2343-6. PubMed ID: 9216712 [TBL] [Abstract][Full Text] [Related]
32. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer. Lehrer S; Diamond EJ; Stagger S; Stone NN; Stock RG Br J Cancer; 2002 Sep; 87(7):726-8. PubMed ID: 12232754 [TBL] [Abstract][Full Text] [Related]
33. Ratios of free to total prostate-specific antigen and total prostate specific antigen to protein concentrations in saliva and serum of healthy men. Ayatollahi H; Darabi Mahboub MR; Mohammadian N; Parizadeh MR; Kianoosh T; Khabbaz Khoob M; Kamalian F Urol J; 2007; 4(4):238-41. PubMed ID: 18270950 [TBL] [Abstract][Full Text] [Related]
34. Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models. Denmeade SR; Sokoll LJ; Chan DW; Khan SR; Isaacs JT Prostate; 2001 Jun; 48(1):1-6. PubMed ID: 11391681 [TBL] [Abstract][Full Text] [Related]
35. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer. Miyata Y; Sakai H; Hayashi T; Kanetake H Prostate; 2003 Feb; 54(2):125-32. PubMed ID: 12497585 [TBL] [Abstract][Full Text] [Related]
36. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
37. The antibody response to Propionibacterium acnes is an independent predictor of serum prostate-specific antigen levels in biopsy-negative men. Shannon BA; Cohen RJ; Garrett KL BJU Int; 2008 Feb; 101(4):429-35. PubMed ID: 17850358 [TBL] [Abstract][Full Text] [Related]
38. Prostate-specific antigen may serve as a pathological predictor in breast cancer. Nariţa D; Anghel A; Motoc M Rom J Morphol Embryol; 2008; 49(2):173-80. PubMed ID: 18516323 [TBL] [Abstract][Full Text] [Related]
39. Prospective multicenter trial to determine the feasibility of collection and predictive ability of breast fluid analysis in postmenopausal women receiving SERMs. Sauter ER; Ganz PA; Ehya H; Hewett JE; Schlatter L; Kliethermes B; Daly MB Breast; 2007 Oct; 16(5):489-94. PubMed ID: 17482465 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of prostate-specific antigen (PSA) membrane test assays for the forensic identification of seminal fluid. Hochmeister MN; Budowle B; Rudin O; Gehrig C; Borer U; Thali M; Dirnhofer R J Forensic Sci; 1999 Sep; 44(5):1057-60. PubMed ID: 10486959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]